Natixis Advisors LLC Boosts Stake in Danaher Corporation $DHR

Natixis Advisors LLC lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 22.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 765,616 shares of the conglomerate’s stock after buying an additional 141,495 shares during the period. Natixis Advisors LLC owned approximately 0.11% of Danaher worth $175,265,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in DHR. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter worth $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC acquired a new stake in shares of Danaher during the second quarter worth $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in shares of Danaher during the third quarter worth $27,000. Finally, Financial Life Planners acquired a new stake in shares of Danaher during the third quarter worth $32,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Down 1.4%

Danaher stock opened at $180.07 on Tuesday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The stock’s 50 day simple moving average is $181.91 and its two-hundred day simple moving average is $207.20. The firm has a market cap of $127.45 billion, a PE ratio of 34.83, a P/E/G ratio of 2.44 and a beta of 0.81.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the firm posted $1.88 EPS. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.

Analyst Ratings Changes

Several equities research analysts have recently commented on DHR shares. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday. Citigroup assumed coverage on Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. Morgan Stanley dropped their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, Argus dropped their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $238.24.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.